Saturday, July 5, 2025

Canada’s Politics and Government News Source Since 1989

Will the government stop the changes to PMPRB?

There has been significant opposition to new regulations, coming into effect on Jan. 1, 2022, from multiple stakeholders who express concerns that this will hollow out Canada’s medical R&D sector and delay the introduction of new drugs here by as much as a decade.

Many patient groups are urging the federal government not to bring in changes to the countries that Canada uses to compare drug prices, as recommended by the Patented Medicine Prices Review Board, which operates at arm’s-length from the Minister of Health Jean-Yves Duclos, pictured on Oct. 26. Many stakeholders worry that the regulations give too much power to an agency that operates at arms length from the government and is reluctant to hear (and sometimes openly dismissive of) input from key stakeholders like the patients who are most affected by drug prices, writes Doug Earle. The Hill Times photograph by Andrew Meade

Opinion
BY DOUG EARLE
December 1, 2021

Opinion | BY DOUG EARLE | December 1, 2021

FOLLOW THE HILL TIMES:

Want to make sure your whole office has the full Hill Times experience?

We have team plans available for companies, organizations, classes, Parliament Hill offices and more. Fill out this form and find out if your team is eligible for a discount.

More Opinion

PSPC’s three-year $17.5-billion spending plan lacks clear roadmap to future goals, say insiders

NewsBY IREM KOCA

With billions on the line and a track record of failed targets, how PSPC plans to deliver on its goals is unclear from its recent departmental plan. 'Fact is, if the department can’t meet the expectations of delivery for this new government, then heads will roll,' says Sahir Khan.

PSPC’s three-year $17.5-billion spending plan lacks clear roadmap to future goals, say insiders

NewsBY IREM KOCA

With billions on the line and a track record of failed targets, how PSPC plans to deliver on its goals is unclear from its recent departmental plan. 'Fact is, if the department can’t meet the expectations of delivery for this new government, then heads will roll,' says Sahir Khan.

Will the government stop the changes to PMPRB?

There has been significant opposition to new regulations, coming into effect on Jan. 1, 2022, from multiple stakeholders who express concerns that this will hollow out Canada’s medical R&D sector and delay the introduction of new drugs here by as much as a decade.

Homebuilding is ready for its tech makeover

Canada’s economic future runs on brain power

Today Tuvalu, tomorrow the world

Certainly in chaos: Canada’s path to unshakable leadership

Connecting regional electricity grids should be Canada’s top nation-building project

Digital services tax retreat risks showing ‘Canada will fold’ in Trump trade talks, warn experts

Finance Canada to boost spending 10 per cent by 2027 as debt costs, transfers rise

Spy agency threat assessment singles out China for ‘aggressive cyber program’

House and Senate steering committee members named

Under pressure

PSPC’s three-year $17.5-billion spending plan lacks clear roadmap to future goals, say insiders

PSPC’s three-year $17.5-billion spending plan lacks clear roadmap to future goals, say insiders

News

Get free news updates

Opinion

Submit a guest opinion article

resources

Follow us

Advertise

subscribe

get help

Get free news updates

Submit a guest opinion article

Will the government stop the changes to PMPRB?

There has been significant opposition to new regulations, coming into effect on Jan. 1, 2022, from multiple stakeholders who express concerns that this will hollow out Canada’s medical R&D sector and delay the introduction of new drugs here by as much as a decade.

Get The Weekend Point of View Newsletter